Browsing Tag
NSCLC
12 posts
Perioperative Nivolumab Boosts NSCLC Survival: CheckMate 77T Trial
[ad_1] Perioperative administration of nivolumab plus chemotherapy bests chemotherapy alone in producing longer event-free survival (EFS) among adult…
May 17, 2024
NSCLC-Related Mortality Improves in Medicaid Expansion States
[ad_1] Thirty- and 90-day survival were better among patients treated through surgical resection for their non–small cell lung…
January 16, 2024
Dr Bazhenova on Perioperative Treatment Selection in EGFR– or ALK-Mutated NSCLC
[ad_1] Lyudmila A. Bazhenova, MD, medical oncologist, professor, medicine, the University of California San Diego (UCSD) Moores Cancer Center,…
December 2, 2023
Insights Into Precision Medicine in NSCLC
[ad_1] Today we are bringing you a conversation between 3 experts on precision medicine in non–small cell lung…
December 1, 2023
Multidisciplinary Collaboration and Molecular Testing Are Integral to Treatment Decision-Making in NSCLC
[ad_1] Lyudmila A. Bazhenova, MD With the integration of neoadjuvant, adjuvant and perioperative chemoimmunotherapy approaches into the non–small…
December 1, 2023
Increasingly Specialized Clinical Trials Accelerate Advances in NSCLC Management
[ad_1] Konstantinos Arnaoutakis, MD Subgroup analyses from non–small cell lung cancer (NSCLC) clinical trials, such as the phase…
November 27, 2023
Dr Ricciuti on PD-L1 Expression and Long-Term Survival Outcomes With PD-L1 Inhibitors in Advanced NSCLC
[ad_1] Biagio Ricciuti, MD, thoracic medical oncologist, staff scientist II, Department of Medicine, Dana-Farber Cancer Institute, discusses the association…
October 1, 2023
Certain Immune Cell Types Linked With ICI Response in Patients With NSCLC
[ad_1] The proportion of certain blood immune cell types, predominately T cells and neutrophils, was linked with response…
August 23, 2023
Machine-Learning Models May Help Determine Brain Metastasis Risk in Patients With NSCLC
[ad_1] Machine learning–aided prediction models are capable of learning the relationship between clinical features and later development of…
August 19, 2023
Long-term benefits of amivantamab continue in post-platinum NSCLC
[ad_1] Long-term data from the CHRYSALIS trial (NCT02609776) continued to demonstrate the clinical benefit of amivantamabvmjw (Rybrevant), according…
May 30, 2023